Washington Real Estate Investment Trust (NYSE:WRE) has acquired 1140 Connecticut Avenue, NW, a twelve story, 184,135 square foot office building with a three level parking garage in Washington, DC, for $80.25 million. WRIT has also entered into a contract to purchase 1227 25th Street, NW, an eight story, 130,434 square foot office building with a two level parking garage in Washington, DC, for $47.0 million. WRIT anticipates closing on 1227 25th Street within 90 days.
Washington Real Estate Investment Trust is an equity real estate investment trust (REIT). The company engages in the ownership, operation, and development of real properties.
Power3 Medical Products, Inc. (OTCBB:PWRM) recently disclosed that Power3 delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
"In preparation for commercialization, our objective at this meeting was to show how Power3's protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer's disease," said Dr. Ira L. Goldknopf, Power3's President and Chief Scientific Officer. "It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3's protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs."
"We are pleased that our blood tests specifically diagnose Alzheimer's in patients, both pre- and post-treatment," said Helen R. Park, MS, Chief Executive Officer of Power3, "and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii."
"We are within striking distance of realizing an Alzheimer's clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions," added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.
Power3 has filed several patent applications for its NuroPro® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.
Through these processes, Power3 has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which Power3 has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, for which Power3 is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
GreenHouse Holdings, Inc. (OTCQB:GRHU) has entered into a strategic partnership with ImageWare Systems, Inc. to provide sustainability and security products and services to government, military and law enforcement agencies, domestically and internationally.
GreenHouse's 1-Link service will now be part of the ImageWare Law Enforcement solution package that is being offered to over 20,000 law enforcement agencies in the United States. In turn, GreenHouse agreed to provide opportunities for IWS within the military and government markets for ImageWare biometric identity management solutions which will be included in the 1-Link platform along with other GreenHouse-offered products and services.
"We are very pleased to be teaming with ImageWare Systems to bundle our security and economically sustainable products and services to government, military and law enforcement agencies," stated John Galt, Executive Chairman and co-founder of GreenHouse Holdings. "ImageWare's patented Biometric Identity Management Solution will fit seamlessly with 1-Link to provide agencies with a complete security package both domestically and abroad."
1-Link, in use today at the Center for Disease Control and Prevention (CDC) and the Commonwealth of Puerto Rico, integrates existing systems and provides enterprise-wide real-time access to data, voice, video, maps, incidents, management reports and resource information using existing infrastructure such as personal computers and mobile devices over TCP/IP, cellular and radio networks. 1-Link can integrate a single agency from the director to the field and can integrate multiple agencies. Each agency selects the information that agency will share securely within and across partner agencies. 1-Linkis a scalable, modular, multi-lingual integrated platform for multiple agencies including healthcare systems, harbors, airports, police, fire, emergency medical services, emergency management agencies, education and other public and private agencies.
"We see teaming with GreenHouse as a win-win opportunity given the strategic fit between our product offerings and target markets," said Jim Miller, ImageWare Systems Chairman and CEO.
ImageWare Systems, Inc. is a leading developer of identity management solutions, providing biometric, secure credential and law enforcement technologies. Scalable for worldwide deployment, the Company's biometric product line includes a multi-biometric engine that is hardware and algorithm independent, enabling the enrollment and management of unlimited population sizes. ImageWare's identification products are used to manage and issue secure credentials including national IDs, passports, driver licenses, smart cards and access control credentials. ImageWare's digital booking products provide law enforcement with integrated mug shot, fingerprint Livescan and investigative capabilities. ImageWare is headquartered in San Diego, with offices in Portland, OR, Washington DC and Canada.
GreenHouse Holdings, Inc. is a leading provider of energy efficiency solutions and sustainable infrastructure products. GreenHouse Holdings designs, engineers and installs disparate products and technologies that produce persistent technical and financial results, by enabling GreenHouse Holdings' clients to monitor and control their energy costs in the most efficient manner possible. GreenHouse Holdings' target markets for energy efficiency solutions include residential, commercial and industrial, as well as government and military markets. In addition, GreenHouse Holdings develops, designs and constructs rapidly deployable, sustainable infrastructure primarily for use in disaster relief and security in austere regions.
Moody's Corp. (NYSE:MCO) announced updated guidance for full-year 2010 revenue and earnings per share. The Company now expects full-year 2010 revenue to increase approximately 13% versus 2009, as compared to previous guidance of high-single to low-double-digit percent growth. In addition, the Company expects full-year 2010 diluted earnings per share to be in the range of $2.08 to $2.14 versus previous guidance of $1.90 to $1.96.The full-year 2010 operating margin is expected to remain in the high-thirties percent range. This reflects previously planned regulatory and technology spending, headcount additions, and incremental expense associated with the stronger full-year outlook.
Moody's Corporation, through its subsidiaries, provides credit ratings and related research, data, and analytical tools; risk management software; and quantitative credit risk measures, credit portfolio management solutions, and training services in the United States, Europe, the Middle East, and Africa.
FBL Financial Group Inc. (NYSE:FFG) will announce its fourth quarter 2010 earnings after the close of market on Thursday, February 3, 2011. The fourth quarter earnings release and financial supplement will be posted on the FBL Financial Group website (www.fblfinancial.com) at that time.FBL Financial Group will hold a conference call to discuss fourth quarter 2010 earnings on Friday, February 4, 2011 at 11:00 a.m. ET. The conference call will be webcast live on the Internet. Investors and interested parties who wish to listen to the call on the Internet may do so at www.fblfinancial.com.
FBL Financial Group, Inc., through its subsidiaries, sells individual life insurance and annuity products in the United States.
Sign-Up For Free Hot Stock Alerts At http://stockhottips.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. StockHotTips.com.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stockhottips.com/disclaimer)Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
Crown Equity Holdings Inc. (CRWE.OB) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (GRHU). In addition to the cash, Crown Equity Holdings Inc. (CRWE.OB) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.